TG THERAPEUTICS, INC. Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain
TG THERAPEUTICS, INC. (TGTX) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain of $7.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain · last filed 2026-08-05
- 2026-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $7.00K.
- 2026-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $95.00K.
- 2025-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $331.00K.
- 2025-09-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $214.00K.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain as first filed |
|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $95.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $331.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $214.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $57.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $27.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $64.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $122.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $64.00K 10-Q · filed 2025-05-09 | $0.00 10-Q · filed 2024-05-06 |
| 2023-12-31 | $30.00K 10-K · filed 2025-03-03 | |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-10 | |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $4.00K 10-Q · filed 2021-08-06 | |
| 2020-12-31 | $1.00K 10-K · filed 2022-03-01 | |
| 2020-06-30 | $26.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $106.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $28.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |